Alberto Carturan
@AlbertoCarturan
Followers
17
Following
13
Media
1
Statuses
9
Joined November 2024
RT @PuneethGuru_: Human T cells are now relatively easy to modify ex vivo, but mouse T cells are a bit finicky. We made a resource in @Natu….
0
1
0
RT @RuellaLab: New @NatureProtocols out!📢.An optimized workflow to generate gene-edited murine CAR T cells for immune-competent models, adv….
0
2
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
359
649
3K
RT @ChildrensPhila: CHOP & @PennMedicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency….
0
157
0
RT @PatriziaPorazzi: Exciting news: EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models @Cancer_Cell….
0
7
0
RT @Cancer_Cell: Online Now: EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models .
0
32
0
RT @jitcancer: New #JITC review: Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for….
0
38
0
📢 Excited to share our @sitcancer review: "Advances in the understanding and therapeutic manipulation of cancer immune responsiveness"! Grateful to Francesco Marincola and @MarcoRuella for the opportunity to contribute!.
pubmed.ncbi.nlm.nih.gov
Cancer immunotherapy-including immune checkpoint inhibition (ICI) and adoptive cell therapy (ACT)-has become a standard, potentially curative treatment for a subset of advanced solid and liquid...
1
1
6
Grateful to #ASH2024 for the chance to present our work on overcoming the absence of CD2:CD58 co-stimulation using an innovative PD1:iCD2 switch receptor. Thanks to my mentor @MarcoRuella and the @RuellaLab for their invaluable support. Excited to delve deeper into this approach!
0
6
13
Overcoming the Lack of CD2:CD58 Costimulation in Chimeric Antigen Receptor T-Cell Immunotherapies 1/504/530305/Overcoming-the-Lack-of-CD2-CD58-Costimulation-in #ASH2024.
0
0
3